[1]
Ucciferri, C. et al. 2025. Efficacy and safety of deflazacort in diabetic subjects infected with SARS-CoV-2. Multidisciplinary Respiratory Medicine. 20, (Oct. 2025). DOI:https://doi.org/10.5826/mrm.2025.1035.